ArticleNorth American Spine Society journal2025
The impact of metabolic syndrome on one-year patient-reported outcomes after lumbar fusion surgery.
Article in North American Spine Society journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiology and treatment trends in cervical, thoracic and lumbar disc herniation- a nationwide analysis.Brain & spine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of Metabolic Syndrome (MetS) is increasing and negatively impacts a variety of surgeries. In lumbar fusions, MetS is associated with an increased risk of complications, however no studies have focused on patient-reported outcome measures (PROMs). The aim of this study was to explore the relationship between MetS and 1-year PROMs in lumbar fusion patients using the Patient-Reported Outcomes Measurement Information System (PROMIS). Methods: Retrospective review of 212 patients who underwent 1- to 3-level lumbar fusion for degenerative pathologies between March 2021 and December 2023 from a single institution was performed. Patients were categorized based on the presence of MetS, defined as having 3 or more qualifying metabolic conditions, and assessed using PROMIS surveys (Physical Function [PF], Mental Health, and Pain Interference) preoperatively and at 1-year postoperatively. Univariate and multivariate analyses were performed to evaluate the impact of MetS on PROMIS improvement. Results: Patients with MetS ( Conclusions: MetS negatively impacts outcomes following lumbar fusion, and this difference in outcomes is not solely explained by obesity. Patients should be encouraged to modify their lifestyle to reduce the adverse effects of MetS on outcomes, and surgeons should consider the impact of MetS on outcomes following lumbar fusion and communicate these expectations with patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.